Latest Earnings Results: Q2 '26
Estimated EPS
-$0.05
Reported EPS
-$0.08
Surprise
-60%
Estimated Rev
$5.29M
Reported Rev
$5.64M
Surprise
+6.58%
$YCBD Q2 '26 Earnings Results & Recap cbdMD expects the Bluebird Botanicals brand to contribute meaningfully to top-line growth and earnings as products roll out and integration efficiencies are realized. The CMS BEI pathway adoption visibility is expected through the second half of the calendar year.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | -$0.03 | -- | -- | N/A |
Q2 '26 | -$0.05 | -$0.08 | -60.00% | MISSED |
Q1 '26 | -$0.06 | -$0.04 | 33.33% | BEAT |
Q4 '25 | -$0.07 | $2.78 | 4071.43% | BEAT |
Q3 '25 | -$0.02 | -$0.21 | -950.00% | MISSED |